Loading clinical trials...
Loading clinical trials...
We intends to conduct a series of original clinical research about PA, and establish a large cohort of PA and essential hypertension patients with long-term follow-up of cardiovascular events, renal end points etc. We will establish a large sample of blood, urine, adrenal tissue of the subjects, and the genomics,metabonomics, proteomics database, to explore the mechanism of the PA and target organ damage, risk factors, diagnostic methods and biomarkers.
This study will include the subjects of a series of studies on hypertension conducted by our team, including essential hypertension, PA subjects, and establish a large sample database and specimen bank through follow-up and omics analysis.
Age
18 - 80 years
Sex
ALL
Healthy Volunteers
No
Qifu Li
Chongqing, Chongqing Municipality, China
Start Date
October 1, 2016
Primary Completion Date
December 31, 2027
Completion Date
December 31, 2028
Last Updated
September 6, 2023
1,500
ESTIMATED participants
no intervention
OTHER
Lead Sponsor
Chongqing Medical University
NCT05405101
NCT06833437
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT07378176